drugset / Trial / NCT04449484
Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study of multiple ascending iv doses of MEDI341 in male and female subjects with Parkinson's Disease.
Timeline
- Start
- 2020-08-04
- Primary completion
- 2022-01-05
- Completion
- 2022-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INDENEBART | Monoclonal antibody | — | Intravenous |